nVerses Capital’s MaxLinear MXL Stock Holding History

nVerses Capital’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,697	Closed	-$204K	–	430
2025 Q4	$204K	Buy	+11,697	New	+$190K	0.46%	138
2024 Q4	–	Sell	-900	Closed	-$13K	–	557
2024 Q3	$13K	Buy	+900	New	+$14.3K	0.01%	864

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

nVerses Capital's MXL Position: Q1 2026 in Review

nVerses Capital sold out of MaxLinear (MXL) in Q1 2026, closing a stake of 11,697 shares — an estimated $204K sold.

nVerses Capital first reported a position in MXL in Q3 2024 and held it in 2 quarters. The position peaked at $204K in Q4 2025. 238 funds tracked by Wall St. Rank hold MXL as of Q1 2026.

nVerses Capital reported no remaining MaxLinear position as of Q1 2026 after selling out during the quarter.
nVerses Capital sold 11,697 MaxLinear shares in Q1 2026, an estimated $204K.
nVerses Capital first reported a position in MaxLinear in Q3 2024 and held it in 2 quarters.
nVerses Capital's MaxLinear position peaked at $204K in Q4 2025.
238 funds tracked by Wall St. Rank held MaxLinear as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.